These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7985587)

  • 21. Early alteration of coronary hemodynamics in late restenosis after coronary angioplasty.
    Wu TC; Chen JW; Chen CI; Mar GY; Hsu NW; Chen YH; Ding YA; Wang SP; Chang MS
    Jpn Heart J; 1999 Sep; 40(5):535-48. PubMed ID: 10888374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiographic analysis of immediate and long-term results of PTCR vs. PTCA in complex lesions (COBRA study).
    Dietz U; Rupprecht HJ; Ekinci O; Dill T; Erbel R; Kuck KH; Abdollahnia R; Rippin G; Meyer J; Hamm C
    Catheter Cardiovasc Interv; 2001 Jul; 53(3):359-67. PubMed ID: 11458414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Luminal narrowing after percutaneous transluminal coronary angioplasty. A multivariate analysis of clinical, procedural and lesion related factors affecting long-term angiographic outcome in the PARK study. Post-Angioplasty Restenosis Ketanserin.
    Melkert R; Violaris AG; Serruys PW
    J Invasive Cardiol; 1994 Jun; 6(5):160-71. PubMed ID: 10155065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matching based on quantitative coronary angiography as a surrogate for randomized studies: comparison between stent implantation and balloon angioplasty of native coronary artery lesions.
    de Jaegere PP; Hermans WR; Rensing BJ; Strauss BH; de Feyter PJ; Serruys PW
    Am Heart J; 1993 Feb; 125(2 Pt 1):310-9. PubMed ID: 8427121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Coronary restenosis: the cardiologist facing problems of definitions].
    Charron P; Montalescot G; Drobinski G; Grosgogeat Y; Thomas D
    Arch Mal Coeur Vaiss; 1995 Jan; 88(1):13-9. PubMed ID: 7646244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
    Serruys PW; Foley DP; Jackson G; Bonnier H; Macaya C; Vrolix M; Branzi A; Shepherd J; Suryapranata H; de Feyter PJ; Melkert R; van Es GA; Pfister PJ
    Eur Heart J; 1999 Jan; 20(1):58-69. PubMed ID: 10075142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary angioplasty in heart transplant recipients: a quantitative angiographic long-term follow-up study.
    Christensen BV; Meyer SM; Iacarella CL; Kubo SH; Wilson RF
    J Heart Lung Transplant; 1994; 13(2):212-20. PubMed ID: 8031802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.
    Serruys PW; Luijten HE; Beatt KJ; Geuskens R; de Feyter PJ; van den Brand M; Reiber JH; ten Katen HJ; van Es GA; Hugenholtz PG
    Circulation; 1988 Feb; 77(2):361-71. PubMed ID: 2962786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting.
    Kuntz RE; Safian RD; Carrozza JP; Fishman RF; Mansour M; Baim DS
    Circulation; 1992 Dec; 86(6):1827-35. PubMed ID: 1451255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term clinical follow-up in patients with angiographic restudy after successful angioplasty.
    Weintraub WS; Ghazzal ZM; Douglas JS; Liberman HA; Morris DC; Cohen CL; King SB
    Circulation; 1993 Mar; 87(3):831-40. PubMed ID: 8443903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of restenosis by vessel size adapted percutaneous transluminal coronary angioplasty using intravascular ultrasound.
    Schroeder S; Baumbach A; Haase KK; Oberhoff M; Marholdt H; Herdeg C; Athanasiadis A; Karsch KR
    Am J Cardiol; 1999 Mar; 83(6):875-9. PubMed ID: 10190402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression of coronary artery disease in non-dilated sites in the months following balloon angioplasty: time-dependent relation with restenosis.
    Benchimol D; Dartigues JF; Benchimol H; Bordier P; Duplàa C; Couffinhal T; Bonnet J
    Eur J Clin Invest; 1995 Dec; 25(12):935-41. PubMed ID: 8719934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group.
    Rensing BJ; Hermans WR; Vos J; Tijssen JG; Rutch W; Danchin N; Heyndrickx GR; Mast EG; Wijns W; Serruys PW
    Circulation; 1993 Sep; 88(3):975-85. PubMed ID: 8353925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of coronary angioscopic findings at coronary angioplasty to angiographic restenosis.
    Bauters C; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Circulation; 1995 Nov; 92(9):2473-9. PubMed ID: 7586347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty.
    Kotamäki M; Laustiola K; Syvänne M; Heikkilä J
    J Intern Med; 1996 Nov; 240(5):293-301. PubMed ID: 8946812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute and one year follow-up results after vessel size adapted PTCA using intracoronary ultrasound.
    Haase KK; Athanasiadis A; Mahrholdt H; Treusch A; Wullen B; Jaramillo C; Baumbach A; Voelker W; Meisner C; Karsch KR
    Eur Heart J; 1998 Feb; 19(2):263-72. PubMed ID: 9519320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of coronary angiographic morphology following restenosis.
    Klein LW; Noveck H; Kramer B; Pourzia F; Lesch M
    Am Heart J; 1990 Jan; 119(1):35-41. PubMed ID: 2296871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short- and long-term clinical and quantitative angiographic results with the new, less shortening Wallstent for vessel reconstruction in chronic total occlusion: a quantitative angiographic study.
    Ozaki Y; Violaris AG; Hamburger J; Melkert R; Foley D; Keane D; de Feyter P; Serruys PW
    J Am Coll Cardiol; 1996 Aug; 28(2):354-60. PubMed ID: 8800109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-year angiographic follow-up of intracoronary Sr90 therapy for restenosis prevention after balloon angioplasty.
    Meerkin D; Joyal M; Tardif JC; Lespérance J; Arsenault A; Lucier G; Bonan R
    Circulation; 2002 Jul; 106(5):539-43. PubMed ID: 12147533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.